Kamimura H - Search Results

1

Development and validation of machine learning model for predicting treatment responders in patients with primary biliary cholangitis.

Kimura N, Takahashi K, Setsu T, Horibata Y, Kaneko Y, Miyazaki H, Ogawa K, Kawata Y, Sakai N, Watanabe Y, Abe H, Kamimura H, Sakamaki A, Yokoo T, Kamimura K, Tsuchiya A, Terai S. Kimura N, et al. Among authors: kamimura h. Hepatol Res. 2024 Jan;54(1):67-77. doi: 10.1111/hepr.13966. Epub 2023 Sep 27. Hepatol Res. 2024. PMID: 37691006

2

A resected case of fibrolamellar hepatocellular carcinoma with chronic hepatitis (type B).

Ishikawa T, Kamimura H, Tsuchiya A, Watanabe K, Seki K, Ohta H, Yoshida T, Musya N, Tsubono T, Sakai Y, Takeda K, Ishihara N, Kamimura T. Ishikawa T, et al. Among authors: kamimura h, kamimura t. Nihon Shokakibyo Gakkai Zasshi. 2007 Jul;104(7):1076-81. Nihon Shokakibyo Gakkai Zasshi. 2007. PMID: 17611385

3

Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a pilot study.

Ishikawa T, Imai M, Kamimura H, Tsuchiya A, Togashi T, Watanabe K, Seki K, Ohta H, Yoshida T, Kamimura T. Ishikawa T, et al. Among authors: kamimura h, kamimura t. World J Gastroenterol. 2007 Nov 7;13(41):5465-70. doi: 10.3748/wjg.v13.i41.5465. World J Gastroenterol. 2007. PMID: 17907289 Free PMC article. Clinical Trial.

4

Clinical efficacy of intra-arterial pharmacokinetic chemotherapy with 5-fluorouracil, CDDP, gemcitabine, and angiotensin-II in patients with advanced pancreatic cancer.

Ishikawa T, Kamimura H, Tsuchiya A, Togashi T, Watanabe K, Seki K, Ohta H, Yoshida T, Takeda K, Kamimura T. Ishikawa T, et al. Among authors: kamimura h, kamimura t. Hepatogastroenterology. 2007 Dec;54(80):2378-82. Hepatogastroenterology. 2007. PMID: 18265669

5

Successful treatment of multiple lung metastases of hepatocellular carcinoma by combined chemotherapy with docetaxel, cisplatin and tegafur/uracil.

Tsuchiya A, Imai M, Kamimura H, Togashi T, Watanabe K, Seki K, Ishikawa T, Ohta H, Yoshida T, Kamimura T. Tsuchiya A, et al. Among authors: kamimura h, kamimura t. World J Gastroenterol. 2009 Apr 14;15(14):1779-81. doi: 10.3748/wjg.15.1779. World J Gastroenterol. 2009. PMID: 19360925 Free PMC article.

6

Therapeutic efficacy of continuous arterial infusion of the protease inhibitor and the antibiotics and via celiac and superior mesenteric artery for severe acute pancreatitis--pilot study.

Ishikawa T, Imai M, Kamimura H, Ushiki T, Tsuchiya A, Togashi T, Watanabe K, Seki K, Ohta H, Yoshida T, Kamimura T. Ishikawa T, et al. Among authors: kamimura h, kamimura t. Hepatogastroenterology. 2009 Mar-Apr;56(90):524-8. Hepatogastroenterology. 2009. PMID: 19579635

7

Clinicopathological analysis of CD133 and NCAM human hepatic stem/progenitor cells in damaged livers and hepatocellular carcinomas.

Tsuchiya A, Kamimura H, Takamura M, Yamagiwa S, Matsuda Y, Sato Y, Nomoto M, Ichida T, Aoyagi Y. Tsuchiya A, et al. Among authors: kamimura h. Hepatol Res. 2009 Nov;39(11):1080-90. doi: 10.1111/j.1872-034X.2009.00559.x. Epub 2009 Jul 10. Hepatol Res. 2009. PMID: 19619253

8

Loss of liver-intestine cadherin in human intrahepatic cholangiocarcinoma promotes angiogenesis by up-regulating metal-responsive transcription factor-1 and placental growth factor.

Takamura M, Yamagiwa S, Wakai T, Tamura Y, Kamimura H, Kato T, Tsuchiya A, Matsuda Y, Shirai Y, Ichida T, Ajioka Y, Aoyagi Y. Takamura M, et al. Among authors: kamimura h. Int J Oncol. 2010 Jan;36(1):245-54. Int J Oncol. 2010. PMID: 19956853

9

Hepatocellular carcinoma with progenitor cell features distinguishable by the hepatic stem/progenitor cell marker NCAM.

Tsuchiya A, Kamimura H, Tamura Y, Takamura M, Yamagiwa S, Suda T, Nomoto M, Aoyagi Y. Tsuchiya A, et al. Among authors: kamimura h. Cancer Lett. 2011 Oct 1;309(1):95-103. doi: 10.1016/j.canlet.2011.05.021. Epub 2011 Jun 12. Cancer Lett. 2011. PMID: 21669487

10

Reduced NKG2D ligand expression in hepatocellular carcinoma correlates with early recurrence.

Kamimura H, Yamagiwa S, Tsuchiya A, Takamura M, Matsuda Y, Ohkoshi S, Inoue M, Wakai T, Shirai Y, Nomoto M, Aoyagi Y. Kamimura H, et al. J Hepatol. 2012 Feb;56(2):381-8. doi: 10.1016/j.jhep.2011.06.017. Epub 2011 Jul 12. J Hepatol. 2012. PMID: 21756848

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

350 results

Search Page